Advertisement
Advertisement
NEW
YSP Clonidine

YSP Clonidine

clonidine

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Concise Prescribing Info
Contents
Clonidine HCl
Indications/Uses
Dosage/Direction for Use
1-2 amp (150-300 mcg) via slow IV or IM inj over 5 min, may be repeated at 3-6 hr intervals as needed.
Contraindications
Hypersensitivity. Severe bradyarrhythmia resulting from either sick sinus syndrome or 2nd- or 3rd-degree AV block.
Special Precautions
History of depression or advanced cerebrovascular disease; clinical DM; mild to moderate bradyarrhythmia eg, low sinus rhythm, cerebral or peripheral perfusion disorders, polyneuropathy & constipation; heart failure or severe CHD. May cause decreased lacrimation in contact lens wearer. Discontinue use for 7 days prior to anaesth use. Avoid abrupt w/drawal. Prolonged & high-dose use. Not to be taken by patients w/ galactose intolerance eg, galactosaemia. Concurrent administration of TCAs. May affect ability to drive & use machines. Hepatic or renal impairment. Avoid use during pregnancy. Not to be used during lactation. Not to be used in neonates. Not recommended in childn & adolescents. Avoid use in childn <2 yr.
Adverse Reactions
Dizziness, sedation; orthostatic hypotension; dry mouth. Depression, sleep disorder; headache; constipation, nausea, salivary gland pain, vomiting; erectile dysfunction; fatigue.
Drug Interactions
Potentiated effects of alcohol, sedatives, hypnotics or other centrally-active substances. Reduced therapeutic effect by NSAIDs. Abolished α2-adrenergic receptor-mediated effects w/ α2-adrenergic receptor blockers eg, phentolamine. Potentiated bradycardic rhythm disturbances w/ β-blockers, digitalis glycosides. Potentiated peripheral vascular disorders by β-blockers. Reduced or abolished effects & provoked or aggravated orthostatic regulation disturbances w/ TCAs, neuroleptics w/ α-receptor blockers. Increased arrhythmogenic potential of high-dose IV haloperidol.
MIMS Class
Other Antihypertensives
ATC Classification
C02AC01 - clonidine ; Belongs to the class of imidazoline receptor agonists, centrally-acting antiadrenergic agents. Used in the treatment of hypertension.
Presentation/Packing
Form
YSP Clonidine soln for inj 150 mcg/mL
Packing/Price
1 mL x 5 × 1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement